Bayer's Q4 adj core profit down on currency effects
LEVERKUSEN, Germany Feb 28 (Reuters) - Bayer, Germany's largest drugmaker, posted a 3.1 percent decline in adjusted core earnings, dampened by a weak Japanese yen and emerging-market currencies, which lowered the euro value of its sales abroad.
Fourth-quarter adjusted earnings before interest, taxes, depreciation and amortisation (EBITDA) slipped to 1.77 billion euros ($2.42 billion), it said on Friday, falling short of the 1.91 billion euro average estimate in a Reuters poll.
The group said it expected adjusted EBITDA to grow by a low- to mid-single-digit percentage in 2014 and that full-year sales would be 41-42 billion euros.
- U.S. and Arab allies launch first strikes on fighters in Syria |
- Argentina's Fernandez to meet billionaire investor Soros in New York
- Israel downs Syrian warplane it says violated its Golan airspace
- Qatar adamant it will host 2022 World Cup despite doubts
- U.S. attack on IS targets in Syria "will be answered" - fighter